Title Information
Title
Anti-PfGBP130 Antibodies Inhibit P. falciparum Growth In vitro
Type of Resource (primo)
dissertations
Name: Personal
Name Part
Johnson, Yannick Ekema
Role
Role Term: Text
creator
Name: Personal
Name Part
Wu, Hannah
Role
Role Term: Text
Reader
Name: Personal
Name Part
Najrana, Tanbir
Role
Role Term: Text
Reader
Name: Personal
Name Part
Kurtis, Jonathan
Role
Role Term: Text
Advisor
Name: Corporate
Name Part
Brown University. Biology and Medicine: Biotechnology
Role
Role Term: Text
sponsor
Origin Information
Copyright Date
2024
Physical Description
Extent
, None p.
digitalOrigin
born digital
Note: thesis
Thesis (Sc. M.)--Brown University, 2024
Genre (aat)
theses
Abstract
Despite decades of effort to develop an effective vaccine against Plasmodium falciparum, malaria remains one of the deadliest diseases in modern times, claiming about 608,000 lives in 2022. To discover new vaccine targets, we used our whole proteome differential screening method27 to identify parasite genes that encode parasite proteins that are uniquely recognized by antibodies expressed by resistant children, but not recognized by antibodies expressed by susceptible children. We identified PfGBP130, a 130 kDa protein expressed on the surface of merozoites. To determine if antibodies to PfGBP130 inhibited parasite growth, we immunized BALB/cJ mice with lipid-encapsulated mRNA encoding PfGBP130. In in vitro growth inhibition assays, we determined that polyclonal anti-PfGBP130 antibodies inhibited Plasmodium falciparum growth by 86%. Thus, PfGBP130 is a potential vaccine target for future malaria vaccine development.
Subject (fast) (authorityURI="http://id.worldcat.org/fast", valueURI="http://id.worldcat.org/fast/01006371")
Topic
Malaria vaccine
Subject
Topic
Blood-stage malaria
Subject
Topic
mRNA
Subject
Topic
Growth Inhibiting Activity
Language
Language Term (ISO639-2B)
English
Record Information
Record Content Source (marcorg)
RPB
Record Creation Date (encoding="iso8601")
20240427